TP is a sporadic, seasonal, rural disorder in which acute ataxia often develops five to six days following a history of walking in grass or low brush, followed by ascending flaccid paralysis.

Bill Nye the Science Guy is temporarily rebranding. For now, he’s “Bill Nye the Ataxia Advocate Guy,” as he aims to bring awareness to a neurological disease that has affected his family for ...

Biohaven has surged driven by promising data from its troriluzole trials for spinocerebellar ataxia and ongoing OCD studies.

Several months after forging a fresh path forward for its troubled Friedreich ataxia (FA) drug vatiquinone, PTC Therapeutics is back with some much-needed positive data. The candidate passed ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.

Promising Results Reported in Early-Phase Gene Therapy Trials for Two Types of Inherited Blindness ...

Promising Results Reported in Early-Phase Gene Therapy Trials for Two Types of Inherited Blindness ...

Explore the significant advancements in early diagnosis and treatment of Gaucher disease, a common lysosomal storage disorder ...

Through a recent communication directed to the Directors/Principals/Deans of all medical colleges/institutes under the ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pregabalin are reviewed. Summary: Pregabalin is the first drug to receive approved ...